This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2003 Jun;18(6):1233-4.

doi: 10.1093/ndt/gfg113.

Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy

Momir Polenakovic, Ladislava Grcevska, Sonja Dzikova

PMID: 12748370
DOI: 10.1093/ndt/gfg113

Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy

Momir Polenakovic et al. Nephrol Dial Transplant. 2003 Jun.

. 2003 Jun;18(6):1233-4.

doi: 10.1093/ndt/gfg113.

Authors

Momir Polenakovic, Ladislava Grcevska, Sonja Dzikova

PMID: 12748370
DOI: 10.1093/ndt/gfg113

No abstract available

PubMed Disclaimer

Similar articles

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
Karim MY, Pisoni CN, Ferro L, Tungekar MF, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR. Karim MY, et al. Rheumatology (Oxford). 2005 Oct;44(10):1317-21. doi: 10.1093/rheumatology/kei019. Epub 2005 Jul 27. Rheumatology (Oxford). 2005. PMID: 16049051
Mycophenolate mofetil in primary glomerulopathies.
Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A. Sepe V, et al. Kidney Int. 2008 Jan;73(2):154-62. doi: 10.1038/sj.ki.5002653. Epub 2007 Nov 7. Kidney Int. 2008. PMID: 17989649 Review.
The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
Choi JY, Kim DK, Kim YW, Yoo TH, Lee JP, Chung HC, Cho KH, An WS, Lee DH, Jung HY, Cho JH, Kim CD, Kim YL, Park SH. Choi JY, et al. J Korean Med Sci. 2018 Feb 26;33(9):e74. doi: 10.3346/jkms.2018.33.e74. J Korean Med Sci. 2018. PMID: 29441742 Free PMC article. Clinical Trial.
Use of mycophenolate mofetil in resistant membranous nephropathy.
Miller G, Zimmerman R 3rd, Radhakrishnan J, Appel G. Miller G, et al. Am J Kidney Dis. 2000 Aug;36(2):250-6. doi: 10.1053/ajkd.2000.8968. Am J Kidney Dis. 2000. PMID: 10922302 Clinical Trial.
Mycophenolate mofetil in nonlupus glomerulonephropathy.
Karim MY, Abbs IC. Karim MY, et al. Lupus. 2005;14 Suppl 1:s39-41. doi: 10.1191/0961203305lu2116oa. Lupus. 2005. PMID: 15803930 Review.

See all similar articles

Cited by

Treatment of idiopathic membranous nephropathy.
Waldman M, Austin HA 3rd. Waldman M, et al. J Am Soc Nephrol. 2012 Oct;23(10):1617-30. doi: 10.1681/ASN.2012010058. Epub 2012 Aug 2. J Am Soc Nephrol. 2012. PMID: 22859855 Free PMC article. Review.
Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.
Chiara M, Menegatti E, Di Simone D, Davit A, Bellis D, Sferch D, De Rosa G, Giachino O, Sena LM, Roccatello D. Chiara M, et al. Clin Exp Immunol. 2005 Feb;139(2):225-35. doi: 10.1111/j.1365-2249.2004.02684.x. Clin Exp Immunol. 2005. PMID: 15654821 Free PMC article.
Controversies in the treatment of idiopathic membranous nephropathy.
Waldman M, Austin HA 3rd. Waldman M, et al. Nat Rev Nephrol. 2009 Aug;5(8):469-79. doi: 10.1038/nrneph.2009.101. Epub 2009 Jul 7. Nat Rev Nephrol. 2009. PMID: 19581908 Free PMC article. Review.
An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.
Appel AS, Appel GB. Appel AS, et al. Nat Clin Pract Nephrol. 2009 Mar;5(3):132-42. doi: 10.1038/ncpneph1036. Epub 2009 Jan 27. Nat Clin Pract Nephrol. 2009. PMID: 19174771 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems